Involvement of MAPKs in ICAM-1 expression in glomerular endothelial cells in diabetic nephropathy

Area of Science:

• Nephrology
• Molecular Biology
• Diabetology

Background:

• Inflammatory processes are key in diabetic nephropathy development.
• Intercellular adhesion molecule-1 (ICAM-1) plays a role in endothelial cell activation.
• Mitogen-activated protein kinase (MAPK) pathways are implicated in cellular stress responses.

Purpose of the Study:

• To investigate the role of MAPK pathways in ICAM-1 expression in glomerular endothelial cells under diabetic conditions.
• To determine if high glucose induces ICAM-1 expression via MAPK activation.
• To examine ICAM-1 expression in the kidneys of diabetic rats.

Main Methods:

• Western blot analysis was used to measure ICAM-1 protein expression and MAPK phosphorylation (ERK, p38, JNK).
• Human glomerular endothelial cells were treated with normal glucose, high glucose (HG), or high mannitol (HM).
• Cells were pre-incubated with specific MAPK inhibitors (ERK, p38, JNK) before HG or HM exposure.

Main Results:

• ICAM-1 expression was elevated in the glomeruli of diabetic rats.
• Both HG and HM treatments increased ICAM-1 expression and MAPK phosphorylation in glomerular endothelial cells.
• Inhibiting ERK, p38, or JNK significantly reduced HG- or HM-induced ICAM-1 expression.

Conclusions:

• Activation of ERK1/2, p38, and JNK signaling cascades contributes to ICAM-1 expression in glomerular endothelial cells.
• MAPK pathways are crucial mediators of endothelial cell activation in diabetic nephropathy.
• Targeting these MAPK pathways may offer therapeutic strategies for diabetic kidney disease.